"Biologics"[ Journal] - Search Results

Year	Number of Results
2007	48
2008	88
2009	45
2010	31
2011	11
2012	46
2013	28
2014	26
2015	17
2016	18
2017	13
2018	20
2019	17
2020	13
2021	40
2022	18
2023	17
2024	6

1

Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy.

Soberanis Pina P, Lheureux S. Soberanis Pina P, et al. Biologics. 2024 Mar 21;18:79-93. doi: 10.2147/BTT.S369783. eCollection 2024. Biologics. 2024. PMID: 38529411 Free PMC article. Review.

2

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector.

Lin W, Yan Y, Huang Q, Zheng D. Lin W, et al. Biologics. 2024 Jan 31;18:61-78. doi: 10.2147/BTT.S436629. eCollection 2024. Biologics. 2024. PMID: 38318098 Free PMC article. Review.

3

Advances with Platelet-Rich Plasma for Bone Healing.

Bacevich BM, Smith RDJ, Reihl AM, Mazzocca AD, Hutchinson ID. Bacevich BM, et al. Biologics. 2024 Jan 25;18:29-59. doi: 10.2147/BTT.S290341. eCollection 2024. Biologics. 2024. PMID: 38299120 Free PMC article. Review.

4

Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing.

Asmamaw Mengstie M, Teshome Azezew M, Asmamaw Dejenie T, Teshome AA, Tadele Admasu F, Behaile Teklemariam A, Tilahun Mulu A, Mekonnen Agidew M, Adugna DG, Geremew H, Abebe EC. Asmamaw Mengstie M, et al. Biologics. 2024 Jan 18;18:21-28. doi: 10.2147/BTT.S429411. eCollection 2024. Biologics. 2024. PMID: 38260716 Free PMC article. Review.

5

Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature.

Zavala-Valencia AC, Velasco-Hidalgo L, Martínez-Avalos A, Castillejos-López M, Torres-Espíndola LM. Zavala-Valencia AC, et al. Biologics. 2024 Jan 16;18:7-19. doi: 10.2147/BTT.S438150. eCollection 2024. Biologics. 2024. PMID: 38250216 Free PMC article. Review.

6

Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis.

Kojima S, Matsumoto S, Koito Y, Miura T, Sekine M, Uehara T, Asano T, Yamaguchi Y, Mashima H. Kojima S, et al. Biologics. 2024 Jan 12;18:1-6. doi: 10.2147/BTT.S436301. eCollection 2024. Biologics. 2024. PMID: 38235068 Free PMC article.

7

Hypoxia Inducible Factor-1α Through ROS/NLRP3 Pathway Regulates the Mechanism of Acute Ischemic Stroke Microglia Scorching Mechanism.

Ma X, Jiao J, Aierken M, Sun H, Chen L. Ma X, et al. Biologics. 2023 Dec 19;17:167-180. doi: 10.2147/BTT.S444714. eCollection 2023. Biologics. 2023. PMID: 38145108 Free PMC article.

8

The Effect of Two Years of Secukinumab Treatment on Bone Metabolism in Patients with Radiographic Axial Spondyloarthritis: Results from Daily Clinical Practice.

Siderius M, Kieskamp SC, Wink F, Kroese FGM, Arends S, Spoorenberg A. Siderius M, et al. Biologics. 2023 Dec 14;17:161-166. doi: 10.2147/BTT.S434318. eCollection 2023. Biologics. 2023. PMID: 38115870 Free PMC article.

9

Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study.

Grazzini S, Conticini E, Falsetti P, D'Alessandro M, Sota J, Terribili R, Baldi C, Fabiani C, Bargagli E, Cantarini L, Frediani B. Grazzini S, et al. Biologics. 2023 Dec 1;17:151-160. doi: 10.2147/BTT.S431818. eCollection 2023. Biologics. 2023. PMID: 38059132 Free PMC article.

10

Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value.

Shehab-Eldeen S, Essa A, Arafat ES, Sleem AS, Alhosary AA, Darwish E, Essa A, Al-Omair OA, Al-Khoufi EA, Al Abdulqader AK, Nada A. Shehab-Eldeen S, et al. Biologics. 2023 Oct 13;17:137-149. doi: 10.2147/BTT.S433872. eCollection 2023. Biologics. 2023. PMID: 37854341 Free PMC article.

11

Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis.

Haddad A, Stein N, Lavi I, Shynkar L, Bergman I, Feldhamer I, Cohen AD, Saliba W, Zisman D. Haddad A, et al. Biologics. 2023 Oct 4;17:129-136. doi: 10.2147/BTT.S425693. eCollection 2023. Biologics. 2023. PMID: 37814674 Free PMC article.

12

Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer.

Zhang Z, Zhang R, Li D. Zhang Z, et al. Biologics. 2023 Sep 21;17:113-128. doi: 10.2147/BTT.S426392. eCollection 2023. Biologics. 2023. PMID: 37767463 Free PMC article. Review.

13

Effectiveness of RCTs Pooling Evidence on Mesenchymal Stem Cell (MSC) Therapeutic Applications During COVID-19 Epidemic: A Systematic Review.

Kandula UR, Wake AD. Kandula UR, et al. Biologics. 2023 May 18;17:85-112. doi: 10.2147/BTT.S404421. eCollection 2023. Biologics. 2023. PMID: 37223116 Free PMC article. Review.

14

New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells.

Długosz-Pokorska A, Perlikowska R, Janecki T, Janecka A. Długosz-Pokorska A, et al. Biologics. 2023 May 15;17:69-83. doi: 10.2147/BTT.S405080. eCollection 2023. Biologics. 2023. PMID: 37213261 Free PMC article.

15

Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer - A Real-Life Experience.

Percik R, Oedegaard Smith C, Leibovici A, Shai A. Percik R, et al. Biologics. 2023 May 3;17:61-67. doi: 10.2147/BTT.S395817. eCollection 2023. Biologics. 2023. PMID: 37163178 Free PMC article.

16

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab.

Wu C, Zhang J, Zhao Y. Wu C, et al. Biologics. 2023 Apr 20;17:57-60. doi: 10.2147/BTT.S400073. eCollection 2023. Biologics. 2023. PMID: 37101561 Free PMC article.

17

Why and How Should Ethiopia Establish a Stem Cell Transplant Service? A Review Article.

Mekonnen S, Farris H. Mekonnen S, et al. Biologics. 2023 Mar 20;17:33-40. doi: 10.2147/BTT.S401289. eCollection 2023. Biologics. 2023. PMID: 36969332 Free PMC article. Review.

18

Critical Response: "Does the Mutation of Cancer Driver Genes IDH1/2 and CD204 Influence Cancer Metabolism and Tumor Associated Macrophage Recruitment in Tumor Microenvironment" [Letter].

Panjaitan NSD, Handayani S, Dewi RM. Panjaitan NSD, et al. Biologics. 2023 Mar 20;17:41-42. doi: 10.2147/BTT.S410506. eCollection 2023. Biologics. 2023. PMID: 36969331 Free PMC article. No abstract available.

19

Demonstration of Safety in Wild Type Mice of npFOXF1, a Novel Nanoparticle-Based Gene Therapy for Alveolar Capillary Dysplasia with Misaligned Pulmonary Veins.

Kohram F, Deng Z, Zhang Y, Al Reza AA, Li E, Kolesnichenko OA, Shukla S, Ustiyan V, Gomez-Arroyo J, Acharya A, Shi D, Kalinichenko VV, Kenny AP. Kohram F, et al. Biologics. 2023 Mar 20;17:43-55. doi: 10.2147/BTT.S400006. eCollection 2023. Biologics. 2023. PMID: 36969329 Free PMC article.

20

Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.

Essa A, Essa ES, El-Deeb SM, Seleem HEM, Al Sahlawi M, Al-Omair OA, Shehab-Eldeen S. Essa A, et al. Biologics. 2023 Mar 19;17:23-32. doi: 10.2147/BTT.S405500. eCollection 2023. Biologics. 2023. PMID: 36969330 Free PMC article.

21

The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment.

Kurdi M, Mulla N, Katib Y, Alsinani T, Hakamy S, Mj Addas B, Malibary H, Halawa TF, S Farhan M, Faizo E, Baeesa S. Kurdi M, et al. Biologics. 2023 Feb 5;17:15-22. doi: 10.2147/BTT.S394556. eCollection 2023. Biologics. 2023. PMID: 36778762 Free PMC article.

22

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis.

van Leeuwen JR, Popov T, Obergfell A, Rabelink TJ, Teng YKO. van Leeuwen JR, et al. Biologics. 2023 Jan 25;17:11-14. doi: 10.2147/BTT.S394843. eCollection 2023. Biologics. 2023. PMID: 36721867 Free PMC article. No abstract available.

23

Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices.

Haroon MM, Hegazy GA, Hassanien MA, Shaker O, Hussein WH. Haroon MM, et al. Biologics. 2023 Jan 18;17:1-9. doi: 10.2147/BTT.S389021. eCollection 2023. Biologics. 2023. PMID: 36698375 Free PMC article.

24

Adherence to Subcutaneous Anti-Tumour Necrosis Factor Treatment in a Cohort of Patients with Rheumatoid Arthritis Before and After the Implementation of a Comprehensive Care Model.

Santos-Moreno P, Sánchez-Vanegas G, Monterrosa-Blanco A, Rodríguez-Vargas GS, Rivero M, Rodriguez P, Calixto OJ, Rojas-Villarraga A, Castro CA. Santos-Moreno P, et al. Biologics. 2022 Nov 21;16:199-209. doi: 10.2147/BTT.S385422. eCollection 2022. Biologics. 2022. PMID: 36440060 Free PMC article.

25

TNF Inhibitors Exert a "Hidden" Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients.

Calvo Alén J, Lavin-Gomez BA, Aurrecoechea E, Guerra Ruiz AR, Martínez Taboada V, Gómez Gerique J. Calvo Alén J, et al. Biologics. 2022 Oct 17;16:187-197. doi: 10.2147/BTT.S364191. eCollection 2022. Biologics. 2022. PMID: 36281333 Free PMC article.

26

Phage Therapy: A Different Approach to Fight Bacterial Infections.

Hibstu Z, Belew H, Akelew Y, Mengist HM. Hibstu Z, et al. Biologics. 2022 Oct 6;16:173-186. doi: 10.2147/BTT.S381237. eCollection 2022. Biologics. 2022. PMID: 36225325 Free PMC article. Review.

27

Biosimilars: Science, Implications, and Potential Outlooks in the Middle East and Africa.

Batran RA, Elmoshneb M, Hussein AS, Hussien OM, Adel F, Elgarhy R, Morsi MI. Batran RA, et al. Biologics. 2022 Oct 6;16:161-171. doi: 10.2147/BTT.S376959. eCollection 2022. Biologics. 2022. PMID: 36225324 Free PMC article. Review.

28

Emerging Therapies for Huntington's Disease - Focus on N-Terminal Huntingtin and Huntingtin Exon 1.

van der Bent ML, Evers MM, Vallès A. van der Bent ML, et al. Biologics. 2022 Sep 30;16:141-160. doi: 10.2147/BTT.S270657. eCollection 2022. Biologics. 2022. PMID: 36213816 Free PMC article. Review.

29

A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances.

Abdulla M, Mohammed N. Abdulla M, et al. Biologics. 2022 Sep 12;16:129-140. doi: 10.2147/BTT.S380027. eCollection 2022. Biologics. 2022. PMID: 36118798 Free PMC article. Review.

30

Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis.

Alorfi NM, Alourfi MM. Alorfi NM, et al. Biologics. 2022 Aug 5;16:119-127. doi: 10.2147/BTT.S367675. eCollection 2022. Biologics. 2022. PMID: 35957978 Free PMC article. Review.

31

Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? - A Cohort Study in a Colombian Population.

Santos-Moreno P, Martinez S, Ibata L, Villarreal L, Rodríguez-Florido F, Rivero M, Rojas-Villarraga A, Galarza-Maldonado C. Santos-Moreno P, et al. Biologics. 2022 Jul 13;16:107-117. doi: 10.2147/BTT.S361164. eCollection 2022. Biologics. 2022. PMID: 35860386 Free PMC article.

32

Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review.

Kandula UR, Wake AD. Kandula UR, et al. Biologics. 2022 Jul 8;16:89-105. doi: 10.2147/BTT.S368152. eCollection 2022. Biologics. 2022. PMID: 35836496 Free PMC article. Review.

33

Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab.

Binkhonain FK, Aldokhayel S, BinJadeed H, Madani A. Binkhonain FK, et al. Biologics. 2022 Jun 23;16:85-88. doi: 10.2147/BTT.S362391. eCollection 2022. Biologics. 2022. PMID: 35769328 Free PMC article.

34

Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician.

Saleh A, Ansari U, Abughazaleh S, Glassner K, Abraham BP. Saleh A, et al. Biologics. 2022 Jun 17;16:67-83. doi: 10.2147/BTT.S335697. eCollection 2022. Biologics. 2022. PMID: 35747234 Free PMC article. Review.

35

Biosimilars in Pediatric IBD: Updated Considerations for Disease Management.

Dipasquale V, Cucinotta U, Romano C. Dipasquale V, et al. Biologics. 2022 Jun 13;16:57-66. doi: 10.2147/BTT.S367032. eCollection 2022. Biologics. 2022. PMID: 35721798 Free PMC article. Review.

36

Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis.

Mykoniatis I, Tsiakaras S, Samarinas M, Anastasiadis A, Symeonidis EN, Sountoulides P. Mykoniatis I, et al. Biologics. 2022 May 20;16:47-55. doi: 10.2147/BTT.S290286. eCollection 2022. Biologics. 2022. PMID: 35619987 Free PMC article. Review.

37

Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response.

Dabi YT, Andualem H, Degechisa ST, Gizaw ST. Dabi YT, et al. Biologics. 2022 May 9;16:35-45. doi: 10.2147/BTT.S365490. eCollection 2022. Biologics. 2022. PMID: 35592358 Free PMC article. Review.

38

Progress in Biological Therapies for Adult-Onset Still's Disease.

Galozzi P, Bindoli S, Doria A, Sfriso P. Galozzi P, et al. Biologics. 2022 Apr 21;16:21-34. doi: 10.2147/BTT.S290329. eCollection 2022. Biologics. 2022. PMID: 35481241 Free PMC article. Review.

39

Continuous Use of Etanercept During Pregnancy Does Not Affect TNF-Alpha Levels in Umbilical Cord Blood.

Nishide M, Yagita M, Kumanogoh A. Nishide M, et al. Biologics. 2022 Mar 31;16:17-19. doi: 10.2147/BTT.S358449. eCollection 2022. Biologics. 2022. PMID: 35386275 Free PMC article.

40

A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon.

Temraz S, Nasr F, Kattan J, Abigerges D, Moukadem W, Farhat F, Maatouk L, Chahine G, Shamseddine A. Temraz S, et al. Biologics. 2022 Feb 21;16:7-15. doi: 10.2147/BTT.S340525. eCollection 2022. Biologics. 2022. PMID: 35221671 Free PMC article.

41

Efficacy of Anti-Tumor Necrosis Factor-α Therapy Against Intestinal Behçet's Disease Complicated by Recurrent Enterocutaneous Fistulae.

Kashima H, Matsumoto S, Kojima S, Koito Y, Miura T, Ishii T, Mashima H. Kashima H, et al. Biologics. 2022 Feb 2;16:1-6. doi: 10.2147/BTT.S348300. eCollection 2022. Biologics. 2022. PMID: 35140458 Free PMC article.

42

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population.

Berman J, Furer V, Berman M, Isakov O, Zisman D, Haddad A, Elkayam O. Berman J, et al. Biologics. 2021 Nov 18;15:463-470. doi: 10.2147/BTT.S326792. eCollection 2021. Biologics. 2021. PMID: 34819720 Free PMC article.

43

State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer.

Basile D, Simionato F, Cappetta A, Garattini SK, Roviello G, Aprile G. Basile D, et al. Biologics. 2021 Nov 3;15:451-462. doi: 10.2147/BTT.S290323. eCollection 2021. Biologics. 2021. PMID: 34764633 Free PMC article. Review.

44

Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers.

Rizzo M, Giannatempo P, Porta C. Rizzo M, et al. Biologics. 2021 Nov 1;15:441-450. doi: 10.2147/BTT.S290311. eCollection 2021. Biologics. 2021. PMID: 34754178 Free PMC article. Review.

45

Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients.

Santos-Moreno P, Martinez S, Ibatá L, Villarreal L, Rivero M, Rojas-Villarraga A. Santos-Moreno P, et al. Biologics. 2021 Oct 22;15:433-440. doi: 10.2147/BTT.S322860. eCollection 2021. Biologics. 2021. PMID: 34712042 Free PMC article.

46

Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia.

Abuasab T, Rowe J, Tvito A. Abuasab T, et al. Biologics. 2021 Oct 18;15:419-431. doi: 10.2147/BTT.S290294. eCollection 2021. Biologics. 2021. PMID: 34703207 Free PMC article. Review.

47

Immunotherapeutic Advances for NSCLC.

Massafra M, Passalacqua MI, Gebbia V, Macrì P, Lazzari C, Gregorc V, Buda C, Altavilla G, Santarpia M. Massafra M, et al. Biologics. 2021 Oct 8;15:399-417. doi: 10.2147/BTT.S295406. eCollection 2021. Biologics. 2021. PMID: 34675481 Free PMC article. Review.

48

Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection.

Madani A, Almuhaideb Q. Madani A, et al. Biologics. 2021 Sep 1;15:375-378. doi: 10.2147/BTT.S317888. eCollection 2021. Biologics. 2021. PMID: 34511879 Free PMC article.

49

Stem Cell Therapy for Burns: Story so Far.

Abdul Kareem N, Aijaz A, Jeschke MG. Abdul Kareem N, et al. Biologics. 2021 Aug 31;15:379-397. doi: 10.2147/BTT.S259124. eCollection 2021. Biologics. 2021. PMID: 34511880 Free PMC article. Review.

50

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease.

Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG. Cazzola M, et al. Biologics. 2021 Aug 27;15:363-374. doi: 10.2147/BTT.S295409. eCollection 2021. Biologics. 2021. PMID: 34475751 Free PMC article. Review.

51

Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing.

Asmamaw M, Zawdie B. Asmamaw M, et al. Biologics. 2021 Aug 21;15:353-361. doi: 10.2147/BTT.S326422. eCollection 2021. Biologics. 2021. PMID: 34456559 Free PMC article. Review.

52

HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma.

Xu Y, Huang Z, Yu X, Li Z, Zheng L, Xu J. Xu Y, et al. Biologics. 2021 Aug 13;15:329-341. doi: 10.2147/BTT.S325019. eCollection 2021. Biologics. 2021. PMID: 34413629 Free PMC article.

53

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician.

Findeisen KE, Sewell J, Ostor AJK. Findeisen KE, et al. Biologics. 2021 Aug 12;15:343-352. doi: 10.2147/BTT.S252575. eCollection 2021. Biologics. 2021. PMID: 34413630 Free PMC article. Review.

54

Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature.

Kołt-Kamińska M, Żychowska M, Reich A. Kołt-Kamińska M, et al. Biologics. 2021 Aug 7;15:317-327. doi: 10.2147/BTT.S323239. eCollection 2021. Biologics. 2021. PMID: 34393480 Free PMC article.

55

View Point: Disease Modification and Cell Secretome Based Approaches in Parkinson's Disease: Are We on the Right Track?

Müller T. Müller T. Biologics. 2021 Jul 29;15:307-316. doi: 10.2147/BTT.S267281. eCollection 2021. Biologics. 2021. PMID: 34349499 Free PMC article. Review.

56

Stem Cell Therapy for Retinal Degeneration: The Evidence to Date.

Sharma A, Jaganathan BG. Sharma A, et al. Biologics. 2021 Jul 27;15:299-306. doi: 10.2147/BTT.S290331. eCollection 2021. Biologics. 2021. PMID: 34349498 Free PMC article. Review.

57

Sensitivity Assessment of Wilms Tumor Gene (WT1) Expression in Glioblastoma using qPCR and Immunohistochemistry and its Association with IDH1 Mutation and Recurrence Interval.

Kurdi M, Butt NS, Baeesa S, Kuerban A, Maghrabi Y, Bardeesi A, Saeedi R, Alghamdi BS, Lary AI, Mohamed F, Hakamy S. Kurdi M, et al. Biologics. 2021 Jul 24;15:289-297. doi: 10.2147/BTT.S323358. eCollection 2021. Biologics. 2021. PMID: 34335021 Free PMC article.

58

High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis.

Elalouf O, Lidar M, Reitblat T, Zisman D, Balbir-Gurman A, Hakakian O, Mashiach T, Almog R, Elkayam O. Elalouf O, et al. Biologics. 2021 Jul 20;15:279-287. doi: 10.2147/BTT.S290169. eCollection 2021. Biologics. 2021. PMID: 34321864 Free PMC article.

59

The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy.

Hamilton G, Plangger A. Hamilton G, et al. Biologics. 2021 Jul 7;15:265-277. doi: 10.2147/BTT.S290305. eCollection 2021. Biologics. 2021. PMID: 34262255 Free PMC article. Review.

60

Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review.

Elsbernd PM, Carter JL. Elsbernd PM, et al. Biologics. 2021 Jun 30;15:255-263. doi: 10.2147/BTT.S267273. eCollection 2021. Biologics. 2021. PMID: 34234409 Free PMC article. Review.

61

Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules.

Bellinato F, Gisondi P, Girolomoni G. Bellinato F, et al. Biologics. 2021 Jun 29;15:247-253. doi: 10.2147/BTT.S290309. eCollection 2021. Biologics. 2021. PMID: 34239295 Free PMC article. Review.

62

An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn's Disease.

Chien TH, Puig A, Khuong T, Kouhkamari MH, Che S, Huang TH. Chien TH, et al. Biologics. 2021 Jun 16;15:237-245. doi: 10.2147/BTT.S310076. eCollection 2021. Biologics. 2021. PMID: 34163137 Free PMC article.

63

Recent Advances in the Treatment of Hemophilia: A Review.

Marchesini E, Morfini M, Valentino L. Marchesini E, et al. Biologics. 2021 Jun 15;15:221-235. doi: 10.2147/BTT.S252580. eCollection 2021. Biologics. 2021. PMID: 34163136 Free PMC article. Review.

64

Monoclonal Antibody Therapies for High Risk Neuroblastoma.

Furman WL. Furman WL. Biologics. 2021 Jun 9;15:205-219. doi: 10.2147/BTT.S267278. eCollection 2021. Biologics. 2021. PMID: 34135571 Free PMC article. Review.

65

Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer.

Tiruneh G/Medhin M, Chekol Abebe E, Sisay T, Berhane N, Bekele T, Asmamaw Dejenie T. Tiruneh G/Medhin M, et al. Biologics. 2021 May 31;15:199-204. doi: 10.2147/BTT.S310312. eCollection 2021. Biologics. 2021. PMID: 34103894 Free PMC article. Review.

66

How Can We Engineer CAR T Cells to Overcome Resistance?

Glover M, Avraamides S, Maher J. Glover M, et al. Biologics. 2021 May 19;15:175-198. doi: 10.2147/BTT.S252568. eCollection 2021. Biologics. 2021. PMID: 34040345 Free PMC article. Review.

67

Antibody Therapies for Large B-Cell Lymphoma.

Novo M, Santambrogio E, Frascione PMM, Rota-Scalabrini D, Vitolo U. Novo M, et al. Biologics. 2021 May 18;15:153-174. doi: 10.2147/BTT.S281618. eCollection 2021. Biologics. 2021. PMID: 34040344 Free PMC article. Review.

68

Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target.

Chekol Abebe E, Mengie Ayele T, Tilahun Muche Z, Asmamaw Dejenie T. Chekol Abebe E, et al. Biologics. 2021 May 6;15:143-152. doi: 10.2147/BTT.S307352. eCollection 2021. Biologics. 2021. PMID: 33986591 Free PMC article. Review.

69

Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review.

Votto M, De Filippo M, Licari A, Marseglia A, De Amici M, Marseglia GL. Votto M, et al. Biologics. 2021 May 5;15:133-142. doi: 10.2147/BTT.S252574. eCollection 2021. Biologics. 2021. PMID: 33981139 Free PMC article. Review.

70

Baculoviruses in Gene Therapy and Personalized Medicine.

Schaly S, Ghebretatios M, Prakash S. Schaly S, et al. Biologics. 2021 Apr 28;15:115-132. doi: 10.2147/BTT.S292692. eCollection 2021. Biologics. 2021. PMID: 33953541 Free PMC article. Review.

71

Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.

Samotij D, Gawron E, Szczęch J, Ostańska E, Reich A. Samotij D, et al. Biologics. 2021 Apr 27;15:107-113. doi: 10.2147/BTT.S302164. eCollection 2021. Biologics. 2021. PMID: 33948082 Free PMC article.

72

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy.

Hawkins ER, D'Souza RR, Klampatsa A. Hawkins ER, et al. Biologics. 2021 Apr 14;15:95-105. doi: 10.2147/BTT.S291768. eCollection 2021. Biologics. 2021. PMID: 33883875 Free PMC article. Review.

73

Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7.

Kubota-Koketsu R, Yunoki M, Okuno Y, Ikuta K. Kubota-Koketsu R, et al. Biologics. 2021 Apr 13;15:87-94. doi: 10.2147/BTT.S291808. eCollection 2021. Biologics. 2021. PMID: 33880014 Free PMC article.

74

Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon.

O'Donnell KL, Marzi A. O'Donnell KL, et al. Biologics. 2021 Mar 18;15:79-86. doi: 10.2147/BTT.S259069. eCollection 2021. Biologics. 2021. PMID: 33776420 Free PMC article. Review.

75

The Current Status of Gene Therapy for the Treatment of Cancer.

Belete TM. Belete TM. Biologics. 2021 Mar 18;15:67-77. doi: 10.2147/BTT.S302095. eCollection 2021. Biologics. 2021. PMID: 33776419 Free PMC article. Review.

76

Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature.

Bounia CA, Theodoropoulou EN, Liossis SC. Bounia CA, et al. Biologics. 2021 Mar 17;15:61-66. doi: 10.2147/BTT.S297712. eCollection 2021. Biologics. 2021. PMID: 33762816 Free PMC article. Review.

77

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis.

Mohammadi R, Aryan A, Omrani MD, Ghaderian SMH, Fazeli Z. Mohammadi R, et al. Biologics. 2021 Mar 2;15:53-59. doi: 10.2147/BTT.S267277. eCollection 2021. Biologics. 2021. PMID: 33688164 Free PMC article. Review.

78

Biologic Treatments of Psoriasis: An Update for the Clinician.

Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J. Brownstone ND, et al. Biologics. 2021 Feb 16;15:39-51. doi: 10.2147/BTT.S252578. eCollection 2021. Biologics. 2021. PMID: 33623366 Free PMC article. Review.

79

Convalescent Plasma for the Treatment of Severe COVID-19.

Franchini M, Liumbruno GM. Franchini M, et al. Biologics. 2021 Feb 4;15:31-38. doi: 10.2147/BTT.S272063. eCollection 2021. Biologics. 2021. PMID: 33574654 Free PMC article. Review.

80

Biologic Therapies for Giant Cell Arteritis.

Harrington R, Al Nokhatha SA, Conway R. Harrington R, et al. Biologics. 2021 Jan 6;15:17-29. doi: 10.2147/BTT.S229662. eCollection 2021. Biologics. 2021. PMID: 33442231 Free PMC article. Review.

81

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab.

Fitzgerald T, Melsheimer R, Lafeuille MH, Lefebvre P, Morrison L, Woodruff K, Lin I, Emond B. Fitzgerald T, et al. Biologics. 2021 Jan 6;15:1-15. doi: 10.2147/BTT.S285610. eCollection 2021. Biologics. 2021. PMID: 33442230 Free PMC article.

82

Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report.

Daham N, AlMuqrin A, Madani A, AlSaif F. Daham N, et al. Biologics. 2020 Nov 11;14:127-129. doi: 10.2147/BTT.S273762. eCollection 2020. Biologics. 2020. PMID: 33204064 Free PMC article.

83

Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study.

Pedersen L, Szecsi PB, Johansen PB, Bjerrum PJ. Pedersen L, et al. Biologics. 2020 Oct 29;14:115-125. doi: 10.2147/BTT.S262511. eCollection 2020. Biologics. 2020. PMID: 33162753 Free PMC article.

84

Glycopeptides as Potential Interventions for COVID-19.

Demsie DG, Gebre AK, Yimer EM, Alema NM, Araya EM, Bantie AT, Allene MD, Gebremedhin H, Yehualaw A, Tafere C, Tadese HT, Amare B, Weldekidan E, Gebrie D. Demsie DG, et al. Biologics. 2020 Oct 13;14:107-114. doi: 10.2147/BTT.S262705. eCollection 2020. Biologics. 2020. PMID: 33116397 Free PMC article. Review.

85

Nucleic Acid Therapy for β-Thalassemia.

d'Arqom A. d'Arqom A. Biologics. 2020 Sep 15;14:95-105. doi: 10.2147/BTT.S265767. eCollection 2020. Biologics. 2020. PMID: 32982166 Free PMC article. Review.

86

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration.

Akyol E, Lotery A. Akyol E, et al. Biologics. 2020 Sep 11;14:83-94. doi: 10.2147/BTT.S252581. eCollection 2020. Biologics. 2020. PMID: 32982165 Free PMC article. Review.

87

A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment.

Wondmkun YT, Mohammed OA. Wondmkun YT, et al. Biologics. 2020 Aug 25;14:77-82. doi: 10.2147/BTT.S266487. eCollection 2020. Biologics. 2020. PMID: 32921981 Free PMC article. Review.

88

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis.

Chimenti MS, D'Antonio A, Conigliaro P, Ferrigno S, Vendola A, Ferraioli M, Triggianese P, Costa L, Caso F, Perricone R. Chimenti MS, et al. Biologics. 2020 Aug 20;14:53-75. doi: 10.2147/BTT.S260754. eCollection 2020. Biologics. 2020. PMID: 32903867 Free PMC article. Review.

89

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases.

Marafini I, Monteleone G. Marafini I, et al. Biologics. 2020 Jun 15;14:47-51. doi: 10.2147/BTT.S257638. eCollection 2020. Biologics. 2020. PMID: 32606588 Free PMC article. Review.

90

Galanin Receptors as Drug Target for Novel Antidepressants: Review.

Demsie DG, Altaye BM, Weldekidan E, Gebremedhin H, Alema NM, Tefera MM, Bantie AT. Demsie DG, et al. Biologics. 2020 Apr 21;14:37-45. doi: 10.2147/BTT.S240715. eCollection 2020. Biologics. 2020. PMID: 32368008 Free PMC article. Review.

91

Autophagy Regulates the Stemness of Cervical Cancer Stem Cells [Retraction].

[No authors listed] [No authors listed] Biologics. 2020 Mar 26;14:35. doi: 10.2147/BTT.S254584. eCollection 2020. Biologics. 2020. PMID: 32273681 Free PMC article.

92

Blinatumomab for the Treatment of Adult B-Cell Acute Lymphoblastic Leukemia: Toward a New Era of Targeted Immunotherapy.

Franquiz MJ, Short NJ. Franquiz MJ, et al. Biologics. 2020 Feb 14;14:23-34. doi: 10.2147/BTT.S202746. eCollection 2020. Biologics. 2020. PMID: 32103893 Free PMC article. Review.

93

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study.

Cimmino MA, Parodi M, Barbieri F, Bombardieri S, Zampogna G, Iagnocco A, Batticciotto A, Sconfienza LM, Sinigaglia L, De Benedetti F, Atzeni F, Sarzi-Puttini P. Cimmino MA, et al. Biologics. 2020 Feb 11;14:13-21. doi: 10.2147/BTT.S209873. eCollection 2020. Biologics. 2020. PMID: 32103892 Free PMC article.

94

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease.

Al Sulais E, AlAmeel T. Al Sulais E, et al. Biologics. 2020 Jan 10;14:1-11. doi: 10.2147/BTT.S236433. eCollection 2020. Biologics. 2020. PMID: 32021084 Free PMC article. Review.

95

Efficacy And Safety Of Adalimumab Biosimilar (Exemptia) In Moderate-To-Severe Steroid-Refractory Ulcerative Colitis Patients: Real-Life Outcomes In Resource-Constrained Setting At 24-Weeks Follow-Up.

Chandra A, Kanth R, Thareja S. Chandra A, et al. Biologics. 2019 Nov 25;13:191-200. doi: 10.2147/BTT.S214518. eCollection 2019. Biologics. 2019. PMID: 31819364 Free PMC article.

96

Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats.

Samsu N, Soeharto S, Rifai M, Rudijanto A. Samsu N, et al. Biologics. 2019 Aug 30;13:179-190. doi: 10.2147/BTT.S214820. eCollection 2019. Biologics. 2019. PMID: 31564826 Free PMC article.

97

Remicade^® (infliximab): 20 years of contributions to science and medicine.

Melsheimer R, Geldhof A, Apaolaza I, Schaible T. Melsheimer R, et al. Biologics. 2019 Jul 30;13:139-178. doi: 10.2147/BTT.S207246. eCollection 2019. Biologics. 2019. PMID: 31440029 Free PMC article. Review.

98

Clinical utility of ramucirumab in non-small-cell lung cancer.

Uprety D. Uprety D. Biologics. 2019 Jul 22;13:133-137. doi: 10.2147/BTT.S175034. eCollection 2019. Biologics. 2019. PMID: 31413541 Free PMC article.

99

Therapeutic drug monitoring of biologics in psoriasis.

Liau MM, Oon HH. Liau MM, et al. Biologics. 2019 Jul 5;13:127-132. doi: 10.2147/BTT.S188286. eCollection 2019. Biologics. 2019. PMID: 31308623 Free PMC article. Review.

100

Antitumor and antibacterial properties of virally encoded cationic sequences.

Colle JH, Périchon B, Garcia A. Colle JH, et al. Biologics. 2019 Jun 25;13:117-126. doi: 10.2147/BTT.S201287. eCollection 2019. Biologics. 2019. PMID: 31417238 Free PMC article.

101

Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab.

Lerkvaleekul B, Treepongkaruna S, Ruangwattanapaisarn N, Treesit T, Vilaiyuk S. Lerkvaleekul B, et al. Biologics. 2019 Jun 14;13:111-116. doi: 10.2147/BTT.S204726. eCollection 2019. Biologics. 2019. PMID: 31354239 Free PMC article.

102

TRIP6 functions as a potential oncogene and facilitated proliferation and metastasis of gastric cancer.

Zhu L, Xu X, Tang Y, Zhu X. Zhu L, et al. Biologics. 2019 Jun 11;13:101-110. doi: 10.2147/BTT.S191863. eCollection 2019. Biologics. 2019. PMID: 31354238 Free PMC article.

103

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG).

Salehzadeh F, Mohammadikebar Y, Enteshary A, Ghanbarpour O, Mirzarahimi M. Salehzadeh F, et al. Biologics. 2019 May 27;13:97-99. doi: 10.2147/BTT.S203753. eCollection 2019. Biologics. 2019. PMID: 31239637 Free PMC article.

104

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic.

Caminati M, Bagnasco D, Vaia R, Senna G. Caminati M, et al. Biologics. 2019 May 22;13:89-95. doi: 10.2147/BTT.S157183. eCollection 2019. Biologics. 2019. PMID: 31190733 Free PMC article.

105

Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau.

Smirnova LM, Vertieva EY, Olisova OY, Anpilogova EM. Smirnova LM, et al. Biologics. 2019 May 20;13:83-87. doi: 10.2147/BTT.S199100. eCollection 2019. Biologics. 2019. PMID: 31190732 Free PMC article.

106

Dupilumab side effect in a patient with atopic dermatitis: a case report study.

Albader SS, Alharbi AA, Alenezi RF, Alsaif FM. Albader SS, et al. Biologics. 2019 May 13;13:79-82. doi: 10.2147/BTT.S195512. eCollection 2019. Biologics. 2019. PMID: 31190731 Free PMC article.

107

Systematic review of immunomodulatory therapies for hidradenitis suppurativa.

Lim SYD, Oon HH. Lim SYD, et al. Biologics. 2019 May 13;13:53-78. doi: 10.2147/BTT.S199862. eCollection 2019. Biologics. 2019. PMID: 31190730 Free PMC article. Review.

108

Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy.

Cruz E, Kayser V. Cruz E, et al. Biologics. 2019 May 1;13:33-51. doi: 10.2147/BTT.S166310. eCollection 2019. Biologics. 2019. PMID: 31118560 Free PMC article. Review.

109

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

Viscido A, Papi C, Latella G, Frieri G. Viscido A, et al. Biologics. 2019 Apr 9;13:23-31. doi: 10.2147/BTT.S179006. eCollection 2019. Biologics. 2019. PMID: 31114154 Free PMC article.

110

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience.

Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M; SIGENP IBD Working Group. Alvisi P, et al. Biologics. 2019 Jan 3;13:13-21. doi: 10.2147/BTT.S183088. eCollection 2019. Biologics. 2019. PMID: 30655661 Free PMC article.

111

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.

Keyel ME, Reynolds CP. Keyel ME, et al. Biologics. 2018 Dec 21;13:1-12. doi: 10.2147/BTT.S114530. eCollection 2019. Biologics. 2018. PMID: 30613134 Free PMC article. Review.

112

The role of microfluidics in protein formulations with pre-programmed functional characteristics.

Meng H, Deng S, You Y, Chan HF. Meng H, et al. Biologics. 2018 Dec 3;12:191-197. doi: 10.2147/BTT.S126725. eCollection 2018. Biologics. 2018. PMID: 30584273 Free PMC article. Review.

113

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation.

Wen M, Xia J, Sun Y, Wang X, Fu X, Zhang Y, Zhang Z, Zhou Y, Li X. Wen M, et al. Biologics. 2018 Nov 30;12:183-190. doi: 10.2147/BTT.S169305. eCollection 2018. Biologics. 2018. PMID: 30555222 Free PMC article.

114

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results.

Nozaki Y, Nagare Y, Ashida C, Tomita D, Okada A, Inoue A, Kinoshita K, Funauchi M, Matsumura I. Nozaki Y, et al. Biologics. 2018 Nov 27;12:171-182. doi: 10.2147/BTT.S187998. eCollection 2018. Biologics. 2018. PMID: 30568425 Free PMC article.

115

Structural and functional comparability study of anti-CD20 monoclonal antibody with reference product.

Singh SK, Pokalwar S, Bose S, Gupta S, Almal S, Ranbhor RS. Singh SK, et al. Biologics. 2018 Nov 23;12:159-170. doi: 10.2147/BTT.S187744. eCollection 2018. Biologics. 2018. PMID: 30538425 Free PMC article.

116

Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies.

Esposti LD, Perrone V, Sangiorgi D, Buda S, Andretta M, Rossini M, Girolomoni G. Esposti LD, et al. Biologics. 2018 Nov 12;12:151-158. doi: 10.2147/BTT.S168691. eCollection 2018. Biologics. 2018. PMID: 30518996 Free PMC article.

117

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis.

Heslinga SC, Konings TC, van der Horst-Bruinsma IE, Kamp O, van Halm VP, de Bruin-Bon H, Peters MJ, Nurmohamed MT. Heslinga SC, et al. Biologics. 2018 Nov 8;12:143-149. doi: 10.2147/BTT.S176806. eCollection 2018. Biologics. 2018. PMID: 30510398 Free PMC article.

118

Two decades with omalizumab: what we still have to learn.

Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E. Incorvaia C, et al. Biologics. 2018 Oct 26;12:135-142. doi: 10.2147/BTT.S180846. eCollection 2018. Biologics. 2018. PMID: 30464389 Free PMC article. Review.

119

Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab.

Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Simsek I. Yazici Y, et al. Biologics. 2018 Oct 25;12:127-134. doi: 10.2147/BTT.S172337. eCollection 2018. Biologics. 2018. PMID: 30498332 Free PMC article.

120

Designing of CD8⁺ and CD8⁺-overlapped CD4⁺ epitope vaccine by targeting late and early proteins of human papillomavirus.

Kaliamurthi S, Selvaraj G, Kaushik AC, Gu KR, Wei DQ. Kaliamurthi S, et al. Biologics. 2018 Oct 2;12:107-125. doi: 10.2147/BTT.S177901. eCollection 2018. Biologics. 2018. PMID: 30323556 Free PMC article.

121

A descriptive analysis of real-world treatment patterns of innovator (Remicade^®) and biosimilar infliximab in an infliximab-naïve Turkish population.

Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Mutlu EA, Simsek I. Yazici Y, et al. Biologics. 2018 Oct 2;12:97-106. doi: 10.2147/BTT.S172241. eCollection 2018. Biologics. 2018. PMID: 30323555 Free PMC article.

122

Focus on biosimilar etanercept - bioequivalence and interchangeability.

Cantini F, Benucci M. Cantini F, et al. Biologics. 2018 Aug 30;12:87-95. doi: 10.2147/BTT.S126854. eCollection 2018. Biologics. 2018. PMID: 30214149 Free PMC article. Review.

123

Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway.

Pan YH, Jiao L, Lin CY, Lu CH, Li L, Chen HY, Wang YB, He Y. Pan YH, et al. Biologics. 2018 Aug 20;12:75-86. doi: 10.2147/BTT.S166867. eCollection 2018. Biologics. 2018. PMID: 30154647 Free PMC article.

124

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn's disease.

Matsumoto S, Mashima H. Matsumoto S, et al. Biologics. 2018 Jul 19;12:69-73. doi: 10.2147/BTT.S169326. eCollection 2018. Biologics. 2018. PMID: 30050284 Free PMC article.

125

The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation.

Hakimian S, Popov Y, Rupawala AH, Salomon-Escoto K, Hatch S, Pellish R. Hakimian S, et al. Biologics. 2018 Feb 27;12:61-67. doi: 10.2147/BTT.S150958. eCollection 2018. Biologics. 2018. PMID: 29520131 Free PMC article.

126

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.

Lundstrom K. Lundstrom K. Biologics. 2018 Feb 9;12:43-60. doi: 10.2147/BTT.S140114. eCollection 2018. Biologics. 2018. PMID: 29445265 Free PMC article. Review.

127

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases.

Benucci M, Damiani A, Li Gobbi F, Bandinelli F, Infantino M, Grossi V, Manfredi M, Noguier G, Meacci F. Benucci M, et al. Biologics. 2018 Jan 31;12:37-41. doi: 10.2147/BTT.S145941. eCollection 2018. Biologics. 2018. PMID: 29430171 Free PMC article.

128

Analytical characterization of recombinant hCG and comparative studies with reference product.

Thennati R, Singh SK, Nage N, Patel Y, Bose SK, Burade V, Ranbhor RS. Thennati R, et al. Biologics. 2018 Jan 30;12:23-35. doi: 10.2147/BTT.S141203. eCollection 2018. Biologics. 2018. PMID: 29430170 Free PMC article.

129

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection.

Navalkele BD, Chopra T. Navalkele BD, et al. Biologics. 2018 Jan 18;12:11-21. doi: 10.2147/BTT.S127099. eCollection 2018. Biologics. 2018. PMID: 29403263 Free PMC article. Review.

130

Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.

Chen YH, de Carvalho HM, Kalyoncu U, Llamado LJQ, Solano G, Pedersen R, Lukina G, Lichauco JJ, Vasilescu RS. Chen YH, et al. Biologics. 2018 Jan 12;12:1-9. doi: 10.2147/BTT.S148606. eCollection 2018. Biologics. 2018. PMID: 29391775 Free PMC article. Review.

131

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

Cantatore FP, Maruotti N, Corrado A, Ribatti D. Cantatore FP, et al. Biologics. 2017 Dec 14;11:123-128. doi: 10.2147/BTT.S143674. eCollection 2017. Biologics. 2017. PMID: 29276377 Free PMC article. Review.

132

Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives.

Yau H, Kinaan M, Quinn SL, Moraitis AG. Yau H, et al. Biologics. 2017 Dec 6;11:115-122. doi: 10.2147/BTT.S108818. eCollection 2017. Biologics. 2017. PMID: 29255345 Free PMC article. Review.

133

Anticholinesterase constituents from the leaves of Spondias mombin L. (Anacardiaceae).

Elufioye TO, Obuotor EM, Agbedahunsi JM, Adesanya SA. Elufioye TO, et al. Biologics. 2017 Aug 2;11:107-114. doi: 10.2147/BTT.S136011. eCollection 2017. Biologics. 2017. PMID: 28814827 Free PMC article.

134

Epigenetic memory of oxidative stress: does nephrilin exert its protective effects via Rac1?

Mascarenhas DD, Herndon DN, Arany I. Mascarenhas DD, et al. Biologics. 2017 Jul 17;11:97-106. doi: 10.2147/BTT.S136188. eCollection 2017. Biologics. 2017. PMID: 28761330 Free PMC article.

135

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma.

Haldar P. Haldar P. Biologics. 2017 Jun 27;11:81-95. doi: 10.2147/BTT.S93954. eCollection 2017. Biologics. 2017. PMID: 28721009 Free PMC article. Review.

136

Autophagy regulates the stemness of cervical cancer stem cells.

Yang Y, Yu L, Li J, Yuan YH, Wang XL, Yan SR, Li DS, Ding Y. Yang Y, et al. Biologics. 2017 Jun 21;11:71-79. doi: 10.2147/BTT.S134920. eCollection 2017. Biologics. 2017. PMID: 28684898 Free PMC article. Retracted.

137

Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn's disease.

Amano H, Matsuda R, Shibata T, Takahashi D, Suzuki S. Amano H, et al. Biologics. 2017 May 22;11:65-69. doi: 10.2147/BTT.S134508. eCollection 2017. Biologics. 2017. PMID: 28579754 Free PMC article.

138

Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties.

Talwar GP, Gupta JC, Mustafa AS, Kar HK, Katoch K, Parida SK, Reddi PP, Ahmed N, Saini V, Gupta S. Talwar GP, et al. Biologics. 2017 May 2;11:55-63. doi: 10.2147/BTT.S128308. eCollection 2017. Biologics. 2017. PMID: 28496303 Free PMC article. Review.

139

CUL4A promotes cell invasion in gastric cancer by activating the NF-κB signaling pathway.

Gong Y, Xiang XJ, Feng M, Chen J, Fang ZL, Xiong JP. Gong Y, et al. Biologics. 2017 Apr 12;11:45-53. doi: 10.2147/BTT.S127650. eCollection 2017. Biologics. 2017. PMID: 28442889 Free PMC article.

140

New developments in the treatment of multiple myeloma - clinical utility of daratumumab.

McEllistrim C, Krawczyk J, O'Dwyer ME. McEllistrim C, et al. Biologics. 2017 Apr 11;11:31-43. doi: 10.2147/BTT.S97633. eCollection 2017. Biologics. 2017. PMID: 28442888 Free PMC article. Review.

141

Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin.

Onodera H, Urayama T, Hirota K, Maeda K, Kubota-Koketsu R, Takahashi K, Hagiwara K, Okuno Y, Ikuta K, Yunoki M. Onodera H, et al. Biologics. 2017 Mar 10;11:23-30. doi: 10.2147/BTT.S123831. eCollection 2017. Biologics. 2017. PMID: 28331286 Free PMC article.

142

A practical guide about biosimilar data for health care providers treating inflammatory diseases.

Markenson J, Alvarez DF, Jacobs I, Kirchhoff C. Markenson J, et al. Biologics. 2017 Feb 24;11:13-21. doi: 10.2147/BTT.S122335. eCollection 2017. Biologics. 2017. PMID: 28280299 Free PMC article. Review.

143

Biosimilars and the extrapolation of indications for inflammatory conditions.

Tesser JR, Furst DE, Jacobs I. Tesser JR, et al. Biologics. 2017 Feb 17;11:5-11. doi: 10.2147/BTT.S124476. eCollection 2017. Biologics. 2017. PMID: 28255229 Free PMC article. Review.

144

Centrosome - a promising anti-cancer target.

Rivera-Rivera Y, Saavedra HI. Rivera-Rivera Y, et al. Biologics. 2016 Dec 13;10:167-176. doi: 10.2147/BTT.S87396. eCollection 2016. Biologics. 2016. PMID: 28008224 Free PMC article. Review.

145

Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars.

Perrone V, Saragoni S, Buda S, Broccoli A, Degli Esposti L. Perrone V, et al. Biologics. 2016 Dec 1;10:157-165. doi: 10.2147/BTT.S114625. eCollection 2016. Biologics. 2016. PMID: 27942203 Free PMC article.

146

Update on sepsis-associated acute kidney injury: emerging targeted therapies.

Doyle JF, Forni LG. Doyle JF, et al. Biologics. 2016 Nov 7;10:149-156. doi: 10.2147/BTT.S87385. eCollection 2016. Biologics. 2016. PMID: 27853353 Free PMC article. Review.

147

Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma.

Chávez-López MG, Zúñiga-García V, Pérez-Carreón JI, Avalos-Fuentes A, Escobar Y, Camacho J. Chávez-López MG, et al. Biologics. 2016 Sep 20;10:139-148. doi: 10.2147/BTT.S87402. eCollection 2016. Biologics. 2016. PMID: 27703327 Free PMC article. Review.

148

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.

Cohan S. Cohan S. Biologics. 2016 Sep 12;10:119-38. doi: 10.2147/BTT.S89218. eCollection 2016. Biologics. 2016. PMID: 27672308 Free PMC article. Review.

149

New targeted treatments for non-small-cell lung cancer - role of nivolumab.

Zago G, Muller M, van den Heuvel M, Baas P. Zago G, et al. Biologics. 2016 Aug 1;10:103-17. doi: 10.2147/BTT.S87878. eCollection 2016. Biologics. 2016. PMID: 27536062 Free PMC article. Review.

150

Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus.

Yunoki M, Kurosu T, Koketsu RK, Takahashi K, Okuno Y, Ikuta K. Yunoki M, et al. Biologics. 2016 Jul 7;10:99-102. doi: 10.2147/BTT.S105650. eCollection 2016. Biologics. 2016. PMID: 27462140 Free PMC article.

151

Guanine nucleotide exchange factor H1 can be a new biomarker of melanoma.

Shi J, Guo B, Zhang Y, Hui Q, Chang P, Tao K. Shi J, et al. Biologics. 2016 Jul 5;10:89-98. doi: 10.2147/BTT.S109643. eCollection 2016. Biologics. 2016. PMID: 27462139 Free PMC article.

152

Effects of fucoidan from Fucus vesiculosus in reducing symptoms of osteoarthritis: a randomized placebo-controlled trial.

Myers SP, Mulder AM, Baker DG, Robinson SR, Rolfe MI, Brooks L, Fitton JH. Myers SP, et al. Biologics. 2016 May 26;10:81-8. doi: 10.2147/BTT.S95165. eCollection 2016. Biologics. 2016. PMID: 27307702 Free PMC article.

153

Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.

van der Hilst JCh, Moutschen M, Messiaen PE, Lauwerys BR, Vanderschueren S. van der Hilst JCh, et al. Biologics. 2016 Apr 4;10:75-80. doi: 10.2147/BTT.S102954. eCollection 2016. Biologics. 2016. PMID: 27110096 Free PMC article.

154

Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers.

Laine J, Jokiranta TS, Eklund KK, Väkeväinen M, Puolakka K. Laine J, et al. Biologics. 2016 Apr 1;10:67-73. doi: 10.2147/BTT.S96982. eCollection 2016. Biologics. 2016. PMID: 27099470 Free PMC article.

155

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years.

Farah Z, Ali S, Price-Kuehne F, Mackworth-Young CG. Farah Z, et al. Biologics. 2016 Mar 22;10:59-66. doi: 10.2147/BTT.S101289. eCollection 2016. Biologics. 2016. PMID: 27069354 Free PMC article.

156

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab.

Benucci M, Meacci F, Grossi V, Infantino M, Manfredi M, Bellio E, Bellio V, Li Gobbi F, Bazzichi L, Moscato P, Caputo D, Saviola G, Talotta R, Sarzi-Puttini P, Atzeni F. Benucci M, et al. Biologics. 2016 Mar 11;10:53-8. doi: 10.2147/BTT.S97234. eCollection 2016. Biologics. 2016. PMID: 27041992 Free PMC article.

157

Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumab.

Petkau JM, Eksteen B. Petkau JM, et al. Biologics. 2016 Mar 9;10:33-52. doi: 10.2147/BTT.S71679. eCollection 2016. Biologics. 2016. PMID: 27022240 Free PMC article. Review.

158

Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib.

Emole J, Talabi T, Pinilla-Ibarz J. Emole J, et al. Biologics. 2016 Feb 26;10:23-31. doi: 10.2147/BTT.S67844. eCollection 2016. Biologics. 2016. PMID: 27013862 Free PMC article. Review.

159

Biosimilars in the management of neutropenia: focus on filgrastim.

Caselli D, Cesaro S, Aricò M. Caselli D, et al. Biologics. 2016 Feb 18;10:17-22. doi: 10.2147/BTT.S73580. eCollection 2016. Biologics. 2016. PMID: 26937170 Free PMC article. Review.

160

Emerging treatments in Castleman disease - a critical appraisal of siltuximab.

Koff JL, Lonial S. Koff JL, et al. Biologics. 2016 Jan 25;10:9-15. doi: 10.2147/BTT.S60523. eCollection 2016. Biologics. 2016. PMID: 26869762 Free PMC article. Review.

161

Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients.

Guariglia R, Martorelli MC, Lerose R, Telesca D, Milella MR, Musto P. Guariglia R, et al. Biologics. 2016 Jan 22;10:1-8. doi: 10.2147/BTT.S58597. eCollection 2016. Biologics. 2016. PMID: 26858523 Free PMC article. Review.

162

Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors.

Fecher LA, Sharfman WH. Fecher LA, et al. Biologics. 2015 Nov 6;9:129-40. doi: 10.2147/BTT.S54179. eCollection 2015. Biologics. 2015. PMID: 26604681 Free PMC article. Review.

163

Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis.

Sangiorgi D, Benucci M, Nappi C, Perrone V, Buda S, Degli Esposti L. Sangiorgi D, et al. Biologics. 2015 Nov 6;9:119-27. doi: 10.2147/BTT.S89286. eCollection 2015. Biologics. 2015. PMID: 26604680 Free PMC article.

164

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al.

Thomsen SF, Sand FL. Thomsen SF, et al. Biologics. 2015 Nov 6;9:117-8. doi: 10.2147/BTT.S98040. eCollection 2015. Biologics. 2015. PMID: 26604679 Free PMC article. No abstract available.

165

Role of collagenase clostridium histolyticum in Peyronie's disease.

Peak TC, Mitchell GC, Yafi FA, Hellstrom WJ. Peak TC, et al. Biologics. 2015 Sep 29;9:107-16. doi: 10.2147/BTT.S65619. eCollection 2015. Biologics. 2015. PMID: 26491251 Free PMC article. Review.

166

Effect of mild aerobic training on the myocardium of mice with chronic Chagas disease.

Preto E, Lima NE, Simardi L, Fonseca FL, Filho AA, Maifrino LB. Preto E, et al. Biologics. 2015 Sep 23;9:87-92. doi: 10.2147/BTT.S85283. eCollection 2015. Biologics. 2015. PMID: 26445527 Free PMC article.

167

Clinical utility of ramucirumab in advanced gastric cancer.

Chan MM, Sjoquist KM, Zalcberg JR. Chan MM, et al. Biologics. 2015 Sep 22;9:93-105. doi: 10.2147/BTT.S62777. eCollection 2015. Biologics. 2015. PMID: 26451083 Free PMC article. Review.

168

Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia.

Frustaci AM, Tedeschi A, Picardi P, Cairoli R, Montillo M. Frustaci AM, et al. Biologics. 2015 Sep 18;9:75-86. doi: 10.2147/BTT.S60503. eCollection 2015. Biologics. 2015. PMID: 26425075 Free PMC article. Review.

169

Giant-cell tumor of bone: treatment options and role of denosumab.

Singh AS, Chawla NS, Chawla SP. Singh AS, et al. Biologics. 2015 Jul 14;9:69-74. doi: 10.2147/BTT.S57359. eCollection 2015. Biologics. 2015. PMID: 26203221 Free PMC article. Review.

170

Localization and upregulation of survivin in cancer health disparities: a clinical perspective.

Khan S, Ferguson Bennit H, Asuncion Valenzuela MM, Turay D, Diaz Osterman CJ, Moyron RB, Esebanmen GE, Ashok A, Wall NR. Khan S, et al. Biologics. 2015 Jul 9;9:57-67. doi: 10.2147/BTT.S83864. eCollection 2015. Biologics. 2015. PMID: 26185415 Free PMC article. Review.

171

Emerging treatments and combinations in the management of NSCLC: clinical potential of nintedanib.

Reck M, Mellemgaard A. Reck M, et al. Biologics. 2015 Jul 1;9:47-56. doi: 10.2147/BTT.S57356. eCollection 2015. Biologics. 2015. PMID: 26170616 Free PMC article. Review.

172

Erratum: New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum].

[No authors listed] [No authors listed] Biologics. 2015 Jun 29;9:45. doi: 10.2147/BTT.S87768. eCollection 2015. Biologics. 2015. PMID: 26170615 Free PMC article.

173

Biologic monotherapy in the treatment of rheumatoid arthritis.

Detert J, Klaus P. Detert J, et al. Biologics. 2015 May 14;9:35-43. doi: 10.2147/BTT.S53361. eCollection 2015. Biologics. 2015. PMID: 26028960 Free PMC article. Review.

174

Role of biologics in intractable urticaria.

Cooke A, Bulkhi A, Casale TB. Cooke A, et al. Biologics. 2015 Apr 13;9:25-33. doi: 10.2147/BTT.S63839. eCollection 2015. Biologics. 2015. PMID: 25926715 Free PMC article. Review.

175

Response to Miller et al: resistant mutations in CML and Ph(+) ALL - role of ponatinib.

Bardy-Bouxin N, Matczak E, Devgan G, Woloj M, Shapiro M. Bardy-Bouxin N, et al. Biologics. 2015 Feb 19;9:23-4. doi: 10.2147/BTT.S79507. eCollection 2015. Biologics. 2015. PMID: 25733805 Free PMC article. No abstract available.

176

Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins.

Benucci M, Li Gobbi F, Meacci F, Manfredi M, Infantino M, Severino M, Testi S, Sarzi-Puttini P, Ricci C, Atzeni F. Benucci M, et al. Biologics. 2015 Feb 17;9:7-12. doi: 10.2147/BTT.S69606. eCollection 2015. Biologics. 2015. PMID: 25733803 Free PMC article.

177

Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia.

Cerquozzi S, Owen C. Cerquozzi S, et al. Biologics. 2015 Feb 16;9:13-22. doi: 10.2147/BTT.S61600. eCollection 2015. Biologics. 2015. PMID: 25733804 Free PMC article. Review.

178

Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries.

Codreanu C, Damjanov N. Codreanu C, et al. Biologics. 2015 Jan 27;9:1-6. doi: 10.2147/BTT.S68949. eCollection 2015. Biologics. 2015. PMID: 25670881 Free PMC article. Review.

179

Multikinase inhibitors use in differentiated thyroid carcinoma.

Jasim S, Ozsari L, Habra MA. Jasim S, et al. Biologics. 2014 Dec 4;8:281-91. doi: 10.2147/BTT.S57619. eCollection 2014. Biologics. 2014. PMID: 25506209 Free PMC article. Review.

180

Inactivation of chromatin remodeling factors sensitizes cells to selective cytotoxic stress.

Freeman MD, Mazu T, Miles JS, Darling-Reed S, Flores-Rozas H. Freeman MD, et al. Biologics. 2014 Nov 14;8:269-80. doi: 10.2147/BTT.S67046. eCollection 2014. Biologics. 2014. PMID: 25484574 Free PMC article.

181

Targeted alpha anticancer therapies: update and future prospects.

Allen BJ, Huang CY, Clarke RA. Allen BJ, et al. Biologics. 2014 Nov 10;8:255-67. doi: 10.2147/BTT.S29947. eCollection 2014. Biologics. 2014. PMID: 25422581 Free PMC article. Review.

182

Resistant mutations in CML and Ph(+)ALL - role of ponatinib.

Miller GD, Bruno BJ, Lim CS. Miller GD, et al. Biologics. 2014 Oct 20;8:243-54. doi: 10.2147/BTT.S50734. eCollection 2014. Biologics. 2014. PMID: 25349473 Free PMC article. Review.

183

Botulinum toxin type A products are not interchangeable: a review of the evidence.

Brin MF, James C, Maltman J. Brin MF, et al. Biologics. 2014 Oct 6;8:227-41. doi: 10.2147/BTT.S65603. eCollection 2014. Biologics. 2014. PMID: 25336912 Free PMC article. Review.

184

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis.

Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C. Frati F, et al. Biologics. 2014 Sep 12;8:221-6. doi: 10.2147/BTT.S50951. eCollection 2014. Biologics. 2014. PMID: 25246765 Free PMC article. Review.

185

Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists.

Urbano PC, Soccol VT, Azevedo VF. Urbano PC, et al. Biologics. 2014 Jul 31;8:211-20. doi: 10.2147/BTT.S57253. eCollection 2014. Biologics. 2014. PMID: 25114503 Free PMC article. Review.

186

Plasma membrane coenzyme Q: evidence for a role in autism.

Crane FL, Löw H, Sun I, Navas P, Gvozdjáková A. Crane FL, et al. Biologics. 2014 May 29;8:199-205. doi: 10.2147/BTT.S53375. eCollection 2014. Biologics. 2014. PMID: 24920882 Free PMC article. Review.

187

Golimumab in unresponsive ulcerative colitis.

Lippert E, Müller M, Ott C. Lippert E, et al. Biologics. 2014 May 27;8:207-10. doi: 10.2147/BTT.S39161. eCollection 2014. Biologics. 2014. PMID: 24904202 Free PMC article. Review.

188

Clinical and comparative utility of afatinib in non-small cell lung cancer.

D'Arcangelo M, Hirsch FR. D'Arcangelo M, et al. Biologics. 2014 Apr 23;8:183-92. doi: 10.2147/BTT.S40567. eCollection 2014. Biologics. 2014. PMID: 24790411 Free PMC article. Review.

189

Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis.

Alawneh KM, Ayesh MH, Khassawneh BY, Saadeh SS, Smadi M, Bashaireh K. Alawneh KM, et al. Biologics. 2014 Apr 22;8:193-8. doi: 10.2147/BTT.S59574. eCollection 2014. Biologics. 2014. PMID: 24790412 Free PMC article.

190

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis.

Kivelevitch D, Mansouri B, Menter A. Kivelevitch D, et al. Biologics. 2014 Apr 17;8:169-82. doi: 10.2147/BTT.S41481. eCollection 2014. Biologics. 2014. PMID: 24790410 Free PMC article. Review.

191

Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility.

Davis-Ajami ML, Wu J, Downton K, Ludeman E, Noxon V. Davis-Ajami ML, et al. Biologics. 2014 Apr 16;8:155-67. doi: 10.2147/BTT.S27578. eCollection 2014. Biologics. 2014. PMID: 24790409 Free PMC article. Review.

192

Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib.

Stjepanovic N, Capdevila J. Stjepanovic N, et al. Biologics. 2014 Apr 10;8:129-39. doi: 10.2147/BTT.S39381. eCollection 2014. Biologics. 2014. PMID: 24748771 Free PMC article. Review.

193

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors.

Tanaka T, Hishitani Y, Ogata A. Tanaka T, et al. Biologics. 2014 Apr 7;8:141-53. doi: 10.2147/BTT.S37509. eCollection 2014. Biologics. 2014. PMID: 24741293 Free PMC article. Review.

194

Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.

Berntorp E, Spotts G, Patrone L, Ewenstein BM. Berntorp E, et al. Biologics. 2014 Apr 5;8:115-27. doi: 10.2147/BTT.S53456. eCollection 2014. Biologics. 2014. PMID: 24741292 Free PMC article. Review.

195

Biologics: the role of delivery systems in improved therapy.

Skalko-Basnet N. Skalko-Basnet N. Biologics. 2014 Mar 19;8:107-14. doi: 10.2147/BTT.S38387. eCollection 2014. Biologics. 2014. PMID: 24672225 Free PMC article. Review.

196

Targeted therapy for sarcomas.

Forscher C, Mita M, Figlin R. Forscher C, et al. Biologics. 2014 Mar 17;8:91-105. doi: 10.2147/BTT.S26555. eCollection 2014. Biologics. 2014. PMID: 24669185 Free PMC article. Review.

197

Porcine dermis implants in soft-tissue reconstruction: current status.

Smart NJ, Bryan N, Hunt JA, Daniels IR. Smart NJ, et al. Biologics. 2014 Mar 10;8:83-90. doi: 10.2147/BTT.S46469. eCollection 2014. Biologics. 2014. PMID: 24648721 Free PMC article. Review.

198

A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations.

Wells AF, Jodat N, Schiff M. Wells AF, et al. Biologics. 2014 Feb 17;8:41-55. doi: 10.2147/BTT.S55783. eCollection 2014. Biologics. 2014. PMID: 24600202 Free PMC article. Review.

199

Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.

Pasadhika S, Rosenbaum JT. Pasadhika S, et al. Biologics. 2014 Feb 15;8:67-81. doi: 10.2147/BTT.S41477. eCollection 2014. Biologics. 2014. PMID: 24600203 Free PMC article. Review.

200

Does the cis/trans configuration of peptide bonds in bioactive tripeptides play a role in ACE-1 enzyme inhibition?

Siltari A, Viitanen R, Kukkurainen S, Vapaatalo H, Valjakka J. Siltari A, et al. Biologics. 2014 Feb 11;8:59-65. doi: 10.2147/BTT.S54056. eCollection 2014. Biologics. 2014. PMID: 24596454 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

497 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

497 results

Results by year